Asklepios Group: Solid third quarter of 2025 –  successful placement of Social Schuldschein loan strengthens financing basis
 

• Patient numbers up 6.3% to reach 2.9 million
• Consolidated revenues of EUR 4,770.1 million
• Successful placement of new Social Schuldschein loan for EUR 600.0 million

 

In the first nine months of 2025, the Asklepios Group put in an overall solid operating performance. Despite healthcare policy challenges and a difficult economic environment, the number of patients was once again increased and consolidated profit was improved. Parallel to that, the Group has also given a significant boost to its sustainable financing.

 

From January to September 2025, the Group’s healthcare facilities treated a total of 2,915,971 patients (9M 2024: 2,742,439) – an increase of roughly 6.3% over the previous year. While moderate growth in patient numbers was observed in the inpatient area, the overall trend was mainly driven by growth in the outpatient area.

 

Consolidated revenue totalled EUR 4,770.1 million (9M 2024: EUR 4,350.8 million) in the first nine months, which is an increase of 9.6%. Consolidated net income after tax (EAT) for the period increased to EUR 114.5 million (9M 2024: EUR 88.2 million). Total investments over the reporting period were EUR 302.8 million (9M 2024: EUR 232.4 million).

 

On 29 October 2025, the Asklepios Group successfully placed a Social Schuldschein loan in the amount of EUR 600.0million. It was issued under the Social Finance Framework for early refinancing of maturities for the years 2025 to 2027 and was subscribed by both existing and international investors. With maturities of 3, 5, 7 and 10 years as well as a 52% share of international investors, the capital base was further diversified.

 

Hafid Rifi, CFO of the Asklepios Group, noted:

“The new Social Schuldschein loan allows us to further develop the strategy of our finance portfolio and to actively manage our maturities. What is especially encouraging is the strong interest shown by international investors, clearly underscoring the trust in our sustainable course.“

 

 

About Asklepios

Asklepios Kliniken is one of the leading operators of private hospitals and healthcare facilities in Germany. The hospital group has an established track record for delivering high-quality medical care to its patients with a clear commitment to medical quality, innovation and social responsibility. Currently, the Asklepios Group has some 160 healthcare facilities throughout Germany. These include acute hospitals of all care levels, university hospitals, specialised clinics, psychiatric and forensic facilities, rehabilitation hospitals, nursing homes and medical care centres. During financial year 2024, over 3.6 million patients were treated at Asklepios’ healthcare facilities. The Group employs more than 70,000 persons.

 

The Quarterly Statement can be accessed as of today at Asklepios - Publikationen.

 

Investor Relations contact:

Sarah Ludwig

Head of Investor Relations

Asklepios Kliniken GmbH & Co. KGaA

Debusweg 3 – 61462 Königstein-Falkenstein

Tel.: +49 6174 9011-72

E-mail: ir@asklepios.com

 

Media contact:

Rune Hoffmann

Head of Corporate Communications & Marketing

Asklepios Kliniken GmbH & Co. KGaA

Rübenkamp 226 – 22307 Hamburg

Tel.: +49 40 1818-82 6630

Fax: +49 40 1818-82 6639

E-mail: presse@asklepios.com

 

 

Visit Asklepios on the Internet, Facebook or YouTube:

www.asklepios.com

www.gesundleben.asklepios.com
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken

 

 

Sign up for the Asklepios Newsletter:

https://www.asklepios.com/konzern/newsletter-anmeldung/

 

Nursing blog: https://wir-sind-pflege.blog/